Weill Medical College of Cornell University, New York, NY, USA.
FEBS J. 2010 Sep;277(18):3652-63. doi: 10.1111/j.1742-4658.2010.07756.x. Epub 2010 Jul 26.
There is ample evidence to suggest that a dramatic decrease in mitochondrial Ca(2+) retention may contribute to the cell death associated with stroke, excitotoxicity, ischemia and reperfusion, and neurodegenerative diseases. Mitochondria from all studied tissues can accumulate and store Ca(2+) , but the maximum Ca(2+) storage capacity varies widely and exhibits striking tissue specificity. There is currently no explanation for this fact. Precipitation of Ca(2+) and phosphate in the mitochondrial matrix has been suggested to be the major form of storage of accumulated Ca(2+) in mitochondria. How this precipitate is formed is not known. The molecular identity of almost all proteins involved in Ca(2+) transport, storage and formation of the permeability transition pore is also unknown. This review summarizes studies aimed at identifying these proteins, and describes the properties of a known mitochondrial protein that may be involved in Ca(2+) transport and the structure of the permeability transition pore.
有充分的证据表明,线粒体钙(Ca(2+))摄取能力的显著下降可能导致与中风、兴奋毒性、缺血再灌注以及神经退行性疾病相关的细胞死亡。所有研究组织的线粒体都可以积累和储存 Ca(2+),但最大的 Ca(2+)储存容量差异很大,并且表现出明显的组织特异性。目前,对于这一事实尚无解释。有人提出,线粒体基质中 Ca(2+)和磷酸盐的沉淀可能是线粒体中积累的 Ca(2+)的主要储存形式。目前尚不清楚这种沉淀是如何形成的。参与 Ca(2+)转运、储存和形成通透性转换孔的几乎所有蛋白质的分子身份也尚不清楚。这篇综述总结了旨在鉴定这些蛋白质的研究,并描述了一种已知的线粒体蛋白的特性,该蛋白可能参与 Ca(2+)转运和通透性转换孔的结构。